Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
Details for Australian Patent Application No. 2002306517 (hide)
International Classifications
Event Publications
19 December 2002 Complete Application Filed
Priority application(s): 60/269,847 21.02.01 US
6 March 2003 Application Open to Public Inspection
Published as AU-B-2002306517
16 August 2007 Assignment before Grant
NPS Pharmaceuticals, Inc. The application has been assigned to NPS Pharmaceuticals, Inc.; AstraZeneca AB 2003
30 August 2007 Application Accepted
Published as AU-B-2002306517
6 December 2007 Assignment before Grant
AstraZeneca AB; NPS Pharmaceuticals, Inc. The application has been assigned to AstraZeneca AB
10 January 2008 Standard Patent Sealed
15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002306518-Power oscillator for control of waveshape and amplitude
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser